MicroRNA-181b stimulates inflammation via the nuclear factor-κB signaling pathway in vitro

Yazhen Wang1, Genxiang Mao1, Yuandong Lv1

  • 1Zhejiang Provincial Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China.

Insights

MicroRNAs (miRNAs) play a role in acute lung injury (ALI). This study found that miR-181b is upregulated in ALI and activates the NF-κB pathway, suggesting it as a potential therapeutic target for this condition.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Acute lung injury (ALI) involves lung edema and inflammation.
  • MicroRNAs (miRNAs) are implicated in human diseases, but their role in ALI is understudied.
  • Understanding miRNA expression and function in ALI is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the expression profile of miRNAs in lipopolysaccharide (LPS)-induced ALI.
  • To determine the specific role of upregulated miR-181b in the inflammatory response in human bronchial epithelial cells (BEAS-2B).
  • To elucidate the molecular mechanism by which miR-181b influences ALI pathogenesis.

Main Methods:

  • miRNA microarray analysis to identify differentially expressed miRNAs.
  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to validate miRNA expression.
  • Cellular assays involving miR-181b overexpression in BEAS-2B cells.
  • Analysis of inflammatory factor expression (e.g., IL-6) and NF-κB pathway components (p65).

Main Results:

  • miR-181b was significantly upregulated in BEAS-2B cells following LPS stimulation.
  • Overexpression of miR-181b led to increased levels of interleukin-6 (IL-6).
  • miR-181b overexpression upregulated p65, a key component of the NF-κB pathway, which was reversed by an NF-κB inhibitor.

Conclusions:

  • miR-181b is involved in the inflammatory process of LPS-induced ALI in human bronchial epithelial cells.
  • The mechanism involves the activation of the NF-κB signaling pathway by miR-181b.
  • miR-181b represents a potential therapeutic target for acute lung injury.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K